ASRT Assertio Therapeutics Inc

USD 1.64 0.00 0
Icon

Assertio Therapeutics Inc (ASRT) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.64

0.00 (0.00)%

USD 0.16B

0.44M

USD 3.19(+94.36%)

N/A

Icon

ASRT

Assertio Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 1.64
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.16B

N/A

USD 1.64

Assertio Therapeutics Inc (ASRT) Stock Forecast

USD 3.19
(+94.36%)

Based on the Assertio Therapeutics Inc stock forecast from 3 analysts, the average analyst target price for Assertio Therapeutics Inc is USD 3.19 over the next 12 months. Assertio Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Assertio Therapeutics Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Assertio Therapeutics Inc’s stock price was USD 1.64. Assertio Therapeutics Inc’s stock price has changed by -1.20% over the past week, +42.61% over the past month and -69.35% over the last year.

No recent analyst target price found for Assertio Therapeutics Inc
No recent average analyst rating found for Assertio Therapeutics Inc

Company Overview Assertio Therapeutics Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute fl...Read More

100 South Saunders Road, Lake Forest, IL, United States, 60045

53

December

USD

USA

Adjusted Closing Price for Assertio Therapeutics Inc (ASRT)

Loading...

Unadjusted Closing Price for Assertio Therapeutics Inc (ASRT)

Loading...

Share Trading Volume for Assertio Therapeutics Inc Shares

Loading...

Compare Performance of Assertio Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ASRT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Assertio Therapeutics Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NBIX
Neurocrine Biosciences Inc 0.00 (0.00%) USD14.84B 39.95 36.15

ETFs Containing ASRT

Symbol Name ASRT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Assertio Therapeutics Inc (ASRT) Stock

Based on ratings from 3 analysts Assertio Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on ASRT's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for ASRT is USD 3.19 over the next 12 months. The maximum analyst target price is USD 4 while the minimum anlayst target price is USD 2.75.

ASRT stock's Price/Earning ratio is 1.20. Our analysis grades ASRT stock's Price / Earning ratio at B-. This means that ASRT stock's Price/Earning ratio is above 18% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange. Based on this ASRT may be undervalued for its sector.

The last closing price of ASRT's stock was USD 1.64.

The most recent market capitalization for ASRT is USD 0.16B.

Based on targets from 3 analysts, the average taret price for ASRT is projected at USD 3.19 over the next 12 months. This means that ASRT's stock price may go up by +94.36% over the next 12 months.

We can't find any ETFs which contains Assertio Therapeutics Inc's stock.

As per our most recent records Assertio Therapeutics Inc has 53 Employees.

Assertio Therapeutics Inc's registered address is 100 South Saunders Road, Lake Forest, IL, United States, 60045. You can get more information about it from Assertio Therapeutics Inc's website at http://www.bnpparibas-am.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...